We collect cookies to analyze our website traffic and performance; we never collect any personal data.Cookies Policy
Accept
Michigan Post
Search
  • Home
  • Trending
  • Michigan
  • World
  • Politics
  • Top Story
  • Business
    • Business
    • Economics
    • Real Estate
    • Startups
    • Autos
    • Crypto & Web 3
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Beauty
    • Art & Books
  • Health
  • Sports
  • Entertainment
  • Education
Reading: J. & J. Booster Protects Against Severe Omicron, Study Says
Share
Font ResizerAa
Michigan PostMichigan Post
Search
  • Home
  • Trending
  • Michigan
  • World
  • Politics
  • Top Story
  • Business
    • Business
    • Economics
    • Real Estate
    • Startups
    • Autos
    • Crypto & Web 3
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Beauty
    • Art & Books
  • Health
  • Sports
  • Entertainment
  • Education
© 2024 | The Michigan Post | All Rights Reserved.
Michigan Post > Blog > Trending > J. & J. Booster Protects Against Severe Omicron, Study Says
Trending

J. & J. Booster Protects Against Severe Omicron, Study Says

By Editorial Board Published December 30, 2021 4 Min Read
Share
J. & J. Booster Protects Against Severe Omicron, Study Says
29 virusbrief jjvax facebookJumbo

A Johnson & Johnson booster shot provided strong protection against the Omicron variant, greatly reducing the risk of hospitalization, according to a clinical trial in South Africa.

The study, which compared more than 69,000 boosted health care workers with a corresponding group of unvaccinated South Africans, found that two shots of the vaccine reduced the risk of hospitalization from Omicron by about 85 percent. In comparison, another study in South Africa found that two shots of the Pfizer-BioNTech vaccine reduced the risk of hospitalization by about 70 percent.

Although the U.S. Food and Drug Administration has authorized the Johnson & Johnson vaccine as a booster shot, the Centers for Disease Control and Prevention recommended that other vaccines be preferred. The C.D.C. raised concerns about rare but life-threatening blood clots that have been linked to the Johnson & Johnson vaccine.

But the authors of the new study, which was published on a preprint server and has not yet been peer-reviewed, said that the results were important for vaccination efforts in Africa, where the Johnson & Johnson vaccine is a mainstay of Covid public health efforts. As the continent braces for a wave of Omicron cases, a second dose of the vaccine could prevent a surge of hospitalizations.

In a different clinical trial that ended in September, when Delta was still the dominant variant worldwide, Johnson & Johnson found that a second dose of its vaccine given eight weeks after the first greatly increased its efficacy. In the U.S. arm of the trial, efficacy against mild to severe Covid-19 rose to 94 percent, compared with 74 percent for one shot. Across trial sites in 10 countries, the vaccine protected all volunteers against severe disease.

Those results prompted South Africa to launch a trial in November among health care workers who had already received one dose of the vaccine between six and nine months earlier. When the Omicron variant began surging across South Africa in late November, the researchers running the trial began tracking how boosted health care workers fared against the variant, finding that it worked well.

This result was somewhat surprising, given that antibodies taken from people who had received one dose of the vaccine failed to block Omicron from infecting cells in laboratory experiments.

It’s possible that the booster shots raised antibodies to protective levels. And while antibodies help the body fend off infections, they are just one of many parts of the immune system.

Certain immune cells help fight Covid by attacking virus-infected cells. In a study posted online on Tuesday, South African researchers found that immune cells taken from people who received Johnson & Johnson vaccines recognized Omicron-infected cells almost as well as they recognized cells infected with other variants.

It’s possible that in addition to raising antibodies, Johnson & Johnson booster shots also increase the army of immune cells that can wage war on Omicron.

TAGGED:Clinical TrialsCoronavirus (2019-nCoV)Coronavirus Omicron VariantDrugs (Pharmaceuticals)Johnson&JohnsonResearchSouth AfricaThe Washington MailVaccination and Immunization
Share This Article
Facebook Twitter Email Copy Link Print

HOT NEWS

Suspect arrested in connection to Henry Ford Hospital taking pictures in Detroit, police say

Suspect arrested in connection to Henry Ford Hospital taking pictures in Detroit, police say

Michigan
August 24, 2025
Girl shot in Clinton County, husband arrested

Girl shot in Clinton County, husband arrested

LANSING, Mich. (WLNS) — A girl was shot and injured by her husband early Sunday…

August 24, 2025
Is it time for gunboats to assist cease the individuals smugglers?

Is it time for gunboats to assist cease the individuals smugglers?

Curbing the ability of judges in asylum circumstances to deal with the migrant lodge disaster…

August 24, 2025
Raised on soccer, Tino Sunseri intends to uphold heritage with UCLA’s offense

Raised on soccer, Tino Sunseri intends to uphold heritage with UCLA’s offense

That thick, wavy black hair as soon as had no place atop Tino Sunseri’s head.Lengthy…

August 24, 2025
Israeli navy strikes Houthi regime in Yemen after ‘repeated assaults’

Israeli navy strikes Houthi regime in Yemen after ‘repeated assaults’

Israel says it has carried out strikes in opposition to Houthi navy targets in Yemen's…

August 24, 2025

YOU MAY ALSO LIKE

Gregory Hatanaka Teases His Biggest Films Yet with No Regrets and The Shout

If you know indie cinema, you know Gregory Hatanaka. The veteran director, producer, and distributor has spent decades zigzagging through…

EntertainmentLifestyleTrending
August 23, 2025

Okay So I Clicked on “Castle” at 2AM and Things Got Weird

Princess. Dragon. Kingdom. Knight. Wait what? So I'm on this website called Embeddings.fyi at like 2 in the morning because…

Trending
August 22, 2025

Tens of millions of individuals threatened by wildfires close to their properties, analysis finds

The variety of folks whose lives or property are in danger from wildfires has surged by virtually 40% in simply…

Tech / Science
August 21, 2025

Retired girls successfully with out a pension for 4 months a 12 months attributable to gender hole, analysis finds

Retired girls successfully go greater than 4 months yearly with out getting a pension when their revenue is in contrast…

Business
August 21, 2025

Welcome to Michigan Post, an esteemed publication of the Enspirers News Group. As a beacon of excellence in journalism, Michigan Post is committed to delivering unfiltered and comprehensive news coverage on World News, Politics, Business, Tech, and beyond.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 | The Michigan Post | All Rights Reserved

Welcome Back!

Sign in to your account

Lost your password?